Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT03734536Not ApplicableTerminated

Treatment of Partial-Thickness Rotator Cuff Tears

Role: collaborator

NCT05278897Not ApplicableUnknown

Hyaluronic Acid for Soft Tissue Injuries

Role: lead

NCT01380444Not ApplicableCompleted

Intramedullary Nail Versus Sliding Hip Screw Inter-Trochanteric Evaluation

Role: collaborator

NCT02981355Phase 4Terminated

Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions

Role: collaborator

NCT00555945Not ApplicableCompleted

Re-Evaluation of GAmma3 Intramedullary Nails in Hip Fracture (REGAIN)

Role: collaborator

All 5 trials loaded